ECT versus Sham for clozapine-resistant schizophrenia: A secondary analysis of a pilot study based on PANSS-30 individual items
Sign Up to like & getrecommendations! Published in 2020 at "Brain Stimulation"
DOI: 10.1016/j.brs.2020.08.008
Abstract: Approximately 60% of patients with treatment-resistant schizophrenia (TRS) do not respond to a trial of clozapine [1]. This is termed clozapine-resistant schizophrenia (CRS). A recent metanalysis showed that clozapine augmentation with ECT is efficacious for… read more here.
Keywords: clozapine resistant; schizophrenia; clozapine; resistant schizophrenia ... See more keywords
Augmentation strategies for clozapine-resistant patients with schizophrenia.
Sign Up to like & getrecommendations! Published in 2020 at "Current pharmaceutical design"
DOI: 10.2174/1381612826666200110102254
Abstract: BACKGROUND Clozapine has been used in treatment-resistant patients with schizophrenia. However, only 40% of patients with treatment-resistant schizophrenia have response to clozapine. Many augmentation strategies have been proposed to treat those clozapine-resistant patients, but the… read more here.
Keywords: patients schizophrenia; clozapine resistant; augmentation strategies; resistant patients ... See more keywords